Immunome
IMNM • NASDAQ
Immunome is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Clay Siegall, with a market cap of $2.5B.
Market Cap$2.5B
Employees62.0
CEOClay Siegall
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 4 weeksQ1 2026
Financials
Immunome FAQ
Common questions about Immunome
Immunome is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $900.0K.
Immunome has approximately 62 employees.